Abigail Fagan
Using genetic tests to tailor antipsychotic treatments to individual patients
Scientists are tapping individuals’ genetic profiles to learn which patients will respond to antipsychotic medication for schizophrenia. The pursuit is ...
Who benefits most from FDA’s ‘accelerated’ drug approvals? Patients or drugmakers?
Increasing reliance on this and other means of moving drugs quickly to market have many critics worried, given that drugmakers ...
